Open AccessSwitching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)
Author(s) -
Jean van Wyk,
F. Ajana,
Fiona Bisshop,
Christoph Stephan,
Y. Osiyemi,
Joaquín Portilla,
JeanPierre Routy,
Christoph Wyen,
Mounir AitKhaled,
M. C. Nascimento,
Keith A. Pappa,
Rachel Y. Wang,
Jackson Wright,
A. Tenorio,
Brian Wynne,
Michael Aboud,
Martin Gartland,
Kate Smith,
Y. El-Bahy
Publication year - 2020
Publication title -
journal of infection and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.983
H-Index - 35
eISSN - 1876-035X
pISSN - 1876-0341
DOI - 10.1016/j.jiph.2020.01.117
Subject(s) - fixed dose combination , regimen , medicine , urology , pharmacology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom